Related Experiment Videos
Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia
Niels P Riksen1, Gerard A Rongen, Henk J Blom
1Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. n.riksen@aig.umcn.nl
Clinical Chemistry and Laboratory Medicine
|October 4, 2005
Summary
A study suggests low adenosine levels in hyperhomocysteinemia patients increase cardiovascular risk. Targeting adenosine uptake may reduce this risk.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Hyperhomocysteinemia is linked to increased cardiovascular risk.
- Adenosine plays a crucial role in cardiovascular protection.
- Enzyme imbalances in hyperhomocysteinemia may affect adenosine levels.
Purpose of the Study:
- To review evidence linking decreased adenosine to cardiovascular risk in hyperhomocysteinemia.
- To explore the role of S-adenosylhomocysteine hydrolase in adenosine metabolism.
- To identify potential therapeutic targets for reducing cardiovascular complications.
Main Methods:
- Review of existing literature on hyperhomocysteinemia and adenosine.
- Analysis of biochemical pathways involving S-adenosylhomocysteine hydrolase.
- Examination of animal studies and patient data on homocysteine and adenosine levels.
Main Results:
- Hyperhomocysteinemia shifts enzyme equilibrium, reducing free adenosine.
- Decreased adenosine impairs protective cardiovascular effects like vasodilation.
- Enhanced cellular adenosine uptake observed in homocystinuria patients.
Conclusions:
- Reduced adenosine concentration is a plausible contributor to cardiovascular risk in hyperhomocysteinemia.
- Adenosine uptake inhibition presents a potential therapeutic strategy.
- Further research into adenosine modulation may offer new treatments for cardiovascular complications.